×
About 73,505 results

ALLMedicine™ Anemia Center

Research & Reviews  21,904 results

The Incidence, Complications and Treatment of Iron Deficiency in Pregnancy.
https://doi.org/10.1111/ejh.13870
European Journal of Haematology; Benson AE, Shatzel JJ et. al.

Sep 26th, 2022 - Iron deficiency and/or iron deficiency anemia complicate nearly 50% of pregnancies globally, negatively impacting both maternal and fetal outcomes. Iron deficiency can cause a range of symptoms that range from aggravating to debilitating including...

Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Larg...
https://doi.org/10.12659/AJCR.937500
The American Journal of Case Reports; Kilani Y, Sohail H et. al.

Sep 25th, 2022 - BACKGROUND Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). While bone marrow (BM) involvement is common in lymphoma, primary bone marrow (PBM) DLBCL is extremely rare. We present a case of PBM DLBCL ...

Clinical features and neurological outcomes in pediatric immune-mediated thrombotic thr...
https://doi.org/10.1002/pbc.29992
Pediatric Blood & Cancer; Graciaa S, Adeagbo S et. al.

Sep 25th, 2022 - Thrombotic thrombocytopenic purpura (TTP) is a potentially life-threatening disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and severely reduced or absent ADAMTS13 (A disintegrin and metalloprotease with thrombospond...

Silmitasertib Plus Gemcitabine and Cisplatin First-Line Therapy in Locally Advanced/Met...
https://doi.org/10.1002/hep.32804
Hepatology (Baltimore, Md.); Borad MJ, Bai LY et. al.

Sep 25th, 2022 - Investigate safety and efficacy of silmitasertib, an oral small molecule casein kinase 2 inhibitor, plus gemcitabine and cisplatin (G+C) versus G+C in locally advanced/metastatic cholangiocarcinoma. Phase 1b/2 study (S4-13-001). In phase 2, patien...

Review of Prosthetic Paravalvular Leaks: Diagnosis and Management.
https://doi.org/10.1007/s11886-022-01744-y
Current Cardiology Reports; Helmy T, Kumar S et. al.

Sep 25th, 2022 - Paravalvular leak (PVL) is a relatively uncommon complication associated with prosthetic valve implantation. PVL can occasionally lead to serious adverse consequences such as congestive heart failure, infective endocarditis, and hemolytic anemia. ...

see more →

Guidelines  26 results

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improvin...
https://doi.org/10.1016/j.kint.2021.03.020
Kidney International; Babitt JL, Eisenga MF et. al.

Apr 12th, 2021 - In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis,...

Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.
https://doi.org/10.1053/j.gastro.2020.08.036
Gastroenterology Ko CW, Siddique SM et. al.

Aug 31st, 2020 - Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Altayar O,|blood,diagnosis,etiology,standards,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagn...

GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.08.043
Gastroenterology

Aug 31st, 2020 - GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.|2020| ,|blood,diagnosis,etiology,standards,methods,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagnosis,pathology,analysis,diag...

AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency ...
https://doi.org/10.1053/j.gastro.2020.06.046
Gastroenterology Ko CW, Siddique SM et. al.

Aug 19th, 2020 - AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Sultan S,|blood,diagnosis,epidemiology,etiology,standards,standards,diagnostic imaging,metabolism,pathology,stan...

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH...
https://doi.org/10.1200/JCO.18.02142
Journal of Clinical Oncology : Official Journal of the Am... Bohlius J, Bohlke K et. al.

Apr 11th, 2019 - To update the American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer. PubMed and the Cochrane Library were searched for randomiz...

see more →

Drugs  1,005 results see all →

Clinicaltrials.gov  2,799 results

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04933539

Sep 23rd, 2022 - Background: Smoldering multiple myeloma (SMM) is a precursor condition to MM defined by the clinical parameters of M-protein >=3.0 g/dL or bone marrow plasma cells >=10%, and absence of end organ disease. Patients with high-risk SMM have a risk of...

Eltrombopag for People With Fanconi Anemia
https://clinicaltrials.gov/ct2/show/NCT03206086

Sep 23rd, 2022 - Fanconi anemia (FA) is a rare genetic disease that often presents as a bone marrow failure (BMF) syndrome but also can affect any other organ. Etiologically, loss of function mutations in more than 21 different gene members of the FA core complex ...

A Study to Gather Information About the Progress and Outcomes of Pregnancy in Women Using Various Vitamin Support Plans Before and During Pregnancy
https://clinicaltrials.gov/ct2/show/NCT05062044

Sep 23rd, 2022 - This is an observational study in which data from the participants who will be taking different vitamin supplementation regimes before and during pregnancy. Vitamin deficiency is a condition where there is not enough vitamins in the body. During p...

In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
https://clinicaltrials.gov/ct2/show/NCT02511028

Sep 23rd, 2022 - Objective The goals of this pilot study are to (1) demonstrate the safety of ferumoxytol, a United States Food and Drug Administration (FDA) approved drug used in the treatment of iron deficiency anemia, as a contrast agent for brain magnetic reso...

Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia
https://clinicaltrials.gov/ct2/show/NCT05073458

Sep 23rd, 2022 - Prospective participants must have primary wAIHA as well as other protocol-defined criteria. After participants have been determined to be eligible for the study, they will be randomized to 1 of 2 treatment groups, with stratification for hemoglob...

see more →

News  3,568 results

Post-Transplant Diabetes Can Be Predicted in Kidney Recipients
https://www.medscape.com/viewarticle/981490

Sep 27th, 2022 - Researchers published the study covered in this summary on Research Square and it has not yet been peer reviewed. Key Takeaways A retrospective, case-control study of kidney transplant recipients in China identified that a combination of the follo...

Children with sickle cell anemia not getting treatments, screening
https://www.mdedge.com/pediatrics/article/258116/hematology/children-sickle-cell-anemia-not-getting-treatments-screening
Marcia Frellick

Sep 21st, 2022 - Fewer than half of children aged 2-16 years with sickle cell anemia are receiving recommended annual screening for stroke, a common complication of the disease, according to a new Vital Signs report from the Centers for Disease Control and Prevent.

Fast Five Quiz: Chronic Myelogenous Leukemia Management
https://www.medscape.com/viewarticle/979891

Sep 21st, 2022 - Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by a three-phase clinical course comprising an initial chronic phase, an accelerated phase, and a blast phase. Most cases of CML are diagnosed in the chronic phase, ...

Children With Sickle Cell Anemia Not Getting Treatments, Screening
https://www.medscape.com/viewarticle/981189

Sep 21st, 2022 - Fewer than half of children aged 2-16 years with sickle cell anemia are receiving recommended annual screening for stroke, a common complication of the disease, according to a new Vital Signs report from the Centers for Disease Control and Prevent...

FDA Fast Tracks Approval of Novel Therapy for Rare Neurologic Disorder
https://www.medscape.com/viewarticle/981025

Sep 19th, 2022 - The US Food and Drug Administration (FDA) has granted accelerated approval to the novel gene therapy elivaldogene autotemcel (Skysona, bluebird bio) for the treatment of cerebral adrenoleukodystrophy (CALD). The therapy "is indicated to slow the p...

see more →

Patient Education  100 results see all →